Fact Sheet for Healthcare Providers: Maverick SARS-CoV-2 Multi-Antigen Serology Panel v2 | NLM

Disaster Information Management Research Center | NLM

Fact Sheet for Healthcare Providers: Maverick SARS-CoV-2 Multi-Antigen Serology Panel v2

10/08/2020 12:00 AM EDT

Source: U.S. Food and Drug Administration (FDA). Published: 10/8/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Maverick SARS-CoV-2 Multi-Antigen Serology Panel v2. The Maverick SARS-CoV-2 Multi-Antigen Serology Panel v2 is authorized for the detection of antibodies to SARS-CoV-2 in human dipotassium EDTA venous whole blood, dipotassium EDTA plasma, and serum. (PDF)